Bank of America’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.33M | Buy |
191,927
+110,513
| +136% | +$852K | ﹤0.01% | 4356 |
|
|
2025
Q4 | $718K | Sell |
81,414
-25,022
| -24% | -$138K | ﹤0.01% | 4704 |
|
|
2025
Q3 | $531K | Sell |
106,436
-43,035
| -29% | -$199K | ﹤0.01% | 5750 |
|
|
2025
Q2 | $706K | Buy |
149,471
+27,909
| +23% | +$122K | ﹤0.01% | 5510 |
|
|
2025
Q1 | $558K | Sell |
121,562
-6,774
| -5% | -$31.6K | ﹤0.01% | 5592 |
|
|
2024
Q4 | $615K | Buy |
128,336
+28,659
| +29% | +$138K | ﹤0.01% | 5388 |
|
|
2024
Q3 | $467K | Buy |
99,677
+22,259
| +29% | +$119K | ﹤0.01% | 5525 |
|
|
2024
Q2 | $437K | Sell |
77,418
-1,130,843
| -94% | -$5.84M | ﹤0.01% | 5427 |
|
|
2024
Q1 | $4.97M | Buy |
1,208,261
+1,181,116
| +4,351% | +$4.73M | ﹤0.01% | 3617 |
|
|
2023
Q4 | $115K | Sell |
27,145
-15,334
| -36% | -$61.9K | ﹤0.01% | 6326 |
|
|
2023
Q3 | $184K | Sell |
42,479
-296,446
| -87% | -$1.65M | ﹤0.01% | 5945 |
|
|
2023
Q2 | $2.23M | Sell |
338,925
-1,292,215
| -79% | -$8.28M | ﹤0.01% | 4124 |
|
|
2023
Q1 | $11.1M | Buy |
1,631,140
+1,345,529
| +471% | +$9.46M | ﹤0.01% | 2723 |
|
|
2022
Q4 | $2.11M | Sell |
285,611
-62,314
| -18% | -$607K | ﹤0.01% | 4209 |
|
|
2022
Q3 | $3.44M | Sell |
347,925
-130,784
| -27% | -$1.38M | ﹤0.01% | 3746 |
|
|
2022
Q2 | $5.22M | Buy |
478,709
+167,879
| +54% | +$1.74M | ﹤0.01% | 3342 |
|
|
2022
Q1 | $3.52M | Sell |
310,830
-77,220
| -20% | -$1.02M | ﹤0.01% | 3998 |
|
|
2021
Q4 | $6.09M | Buy |
388,050
+80,274
| +26% | +$1.4M | ﹤0.01% | 3450 |
|
|
2021
Q3 | $5.28M | Buy |
307,776
+29,713
| +11% | +$520K | ﹤0.01% | 3510 |
|
|
2021
Q2 | $5.98M | Buy |
278,063
+25,551
| +10% | +$457K | ﹤0.01% | 3356 |
|
|
2021
Q1 | $3.79M | Buy |
252,512
+33,549
| +15% | +$543K | ﹤0.01% | 3679 |
|
|
2020
Q4 | $2.88M | Sell |
218,963
-71,805
| -25% | -$864K | ﹤0.01% | 3627 |
|
|
2020
Q3 | $2.81M | Buy |
290,768
+47,367
| +19% | +$506K | ﹤0.01% | 3412 |
|
|
2020
Q2 | $2.79M | Buy |
243,401
+8,442
| +4% | +$95.6K | ﹤0.01% | 3353 |
|
|
2020
Q1 | $2.44M | Buy |
234,959
+42,779
| +22% | +$530K | ﹤0.01% | 3332 |
|
|
2019
Q4 | $3.15M | Sell |
192,180
-33,829
| -15% | -$511K | ﹤0.01% | 3646 |
|
|
2019
Q3 | $3M | Sell |
226,009
-243,589
| -52% | -$3.39M | ﹤0.01% | 3682 |
|
|
2019
Q2 | $6.62M | Sell |
469,598
-151,052
| -24% | -$2.4M | ﹤0.01% | 2960 |
|
|
2019
Q1 | $11.4M | Buy |
620,650
+314,638
| +103% | +$7.17M | ﹤0.01% | 2353 |
|
|
2018
Q4 | $8M | Sell |
306,012
-21,618
| -7% | -$508K | ﹤0.01% | 2518 |
|
|
2018
Q3 | $7.52M | Buy |
327,630
+137,694
| +72% | +$2.81M | ﹤0.01% | 2785 |
|
|
2018
Q2 | $3.62M | Buy |
189,936
+6,040
| +3% | +$101K | ﹤0.01% | 3460 |
|
|
2018
Q1 | $3.1M | Buy |
183,896
+14,741
| +9% | +$247K | ﹤0.01% | 3511 |
|
|
2017
Q4 | $2.57M | Sell |
169,155
-22,129
| -12% | -$328K | ﹤0.01% | 3736 |
|
|
2017
Q3 | $3.42M | Buy |
191,284
+73,034
| +62% | +$1.22M | ﹤0.01% | 3526 |
|
|
2017
Q2 | $1.93M | Buy |
118,250
+48,435
| +69% | +$698K | ﹤0.01% | 3919 |
|
|
2017
Q1 | $977K | Buy |
69,815
+9,439
| +16% | +$135K | ﹤0.01% | 4446 |
|
|
2016
Q4 | $963K | Buy |
60,376
+23,071
| +62% | +$371K | ﹤0.01% | 4373 |
|
|
2016
Q3 | $621K | Buy |
37,305
+899
| +2% | +$12.1K | ﹤0.01% | 4481 |
|
|
2016
Q2 | $407K | Buy |
36,406
+17,514
| +93% | +$170K | ﹤0.01% | 4784 |
|
|
2016
Q1 | $158K | Sell |
18,892
-12,568
| -40% | -$103K | ﹤0.01% | 5265 |
|
|
2015
Q4 | $293K | Buy |
31,460
+44
| +0.1% | +$439 | ﹤0.01% | 5129 |
|
|
2015
Q3 | $354K | Sell |
31,416
-27,852
| -47% | -$341K | ﹤0.01% | 5026 |
|
|
2015
Q2 | $752K | Buy |
59,268
+2,761
| +5% | +$29.8K | ﹤0.01% | 4355 |
|
|
2015
Q1 | $526K | Buy |
56,507
+47,864
| +554% | +$541K | ﹤0.01% | 4280 |
|
|
2014
Q4 | $124K | Sell |
8,643
-5,778
| -40% | -$68.4K | ﹤0.01% | 5735 |
|
|
2014
Q3 | $149K | Buy |
14,421
+281
| +2% | +$3.68K | ﹤0.01% | 5678 |
|
|
2014
Q2 | $229K | Buy |
14,140
+6,194
| +78% | +$82.5K | ﹤0.01% | 5429 |
|
|
2014
Q1 | $129K | Sell |
7,946
-111,302
| -93% | -$1.58M | ﹤0.01% | 5771 |
|
|
2013
Q4 | $1.48M | Sell |
119,248
-122,674
| -51% | -$1.23M | ﹤0.01% | 3638 |
|
|
2013
Q3 | $2.65M | Buy |
241,922
+1,731
| +0.7% | +$18.5K | ﹤0.01% | 2973 |
|
|
2013
Q2 | $1.94M | Buy |
+240,191
| New | +$1.62M | ﹤0.01% | 3245 |
|
Other funds holding VNDA
ACM
VCM
Bank of America's VNDA Position: Q1 2026 in Review
Bank of America increased its Vanda Pharmaceuticals (VNDA) stake by 136% in Q1 2026, buying an estimated $852K and bringing the position to 191,927 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #4356.
Bank of America first reported a position in VNDA in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.4M in Q1 2019. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.
- Bank of America held 191,927 shares of Vanda Pharmaceuticals worth $1.33M as of Q1 2026.
- Bank of America bought 110,513 Vanda Pharmaceuticals shares in Q1 2026, an estimated $852K.
- Vanda Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4356 holding.
- Bank of America first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Vanda Pharmaceuticals position peaked at $11.4M in Q1 2019.
- 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.